Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04776642
Other study ID # 2014_054#A201436
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date December 18, 2014
Est. completion date January 2030

Study information

Verified date January 2024
Source Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Contact Elise Hulsman, Bc RN
Phone 31205665653
Email e.l.hulsman@amsterdamumc.nl
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

The 'ADAPT' Biobank is a collection of body material and data from patients with or at risk of cardiac arrhythmias who underwent or will undergo (non-) invasive treatment for this disease. Its main objective is to obtain a comprehensive collection of patient information and material to facilitate research and gain better insight into the complex pathophysiology of the different arrhythmias, the multifactorial process, the heterogeneity in clinical presentation, and prognosis. Bodily material is used for biochemical marker assessments, histological and molecular analyses for research in cardiac arrhythmias.


Description:

The pathophysiological process of many cardiac arrhythmias is complex because of its multifactorial character. Despite extensive research that has already been performed in the field of electrophysiology the exact pathophysiological process of the different arrhythmias remains incompletely understood. The ability to identify subgroups of patients within a population with the same type of arrhythmia that can benefit from a specific treatment strategy might provide more individualized therapeutic opportunities, improve prognostication or provide preventive opportunities in patient with cardiac arrhythmias. Biobanks can make a valuable contribution to the development of diagnostic, preventive and therapeutic methods. More insights into the correlations between genes, environmental factors and susceptibility to illness may be of great value. The 'ADAPT' Biobank has been designed to establish a systematic and qualitative collection of bodily materials for future research in the cardiovascular field. The Biobank includes bodily material of patients with cardiac arrhythmias undergoing (non-) invasive treatment or control patients undergoing cardiothoracic surgery. Clinical data related to the cardiac arrhythmic disease is recorded. The data and samples will be linked to the participants' medical records to allow longitudinal follow-up.


Recruitment information / eligibility

Status Recruiting
Enrollment 1000
Est. completion date January 2030
Est. primary completion date January 2030
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion criteria: - Patients visiting the AMC outpatient clinic - Patients included in an ongoing clinical trial linked to this biobank. Studies are listed under point "Groups and interventions" and include: - MARK AF - INDICO AF - PREDICT AF - WEIGHTLOSS AF - MAD AF - Patients included in future clinical trial linked to this biobank. Studies may be linked to this biobank that investigates prevalent or incident cardiac arrhythmias. - Cardiac arrhtymias are defined as - Supraventricular tachycardia, among which the most common are: - Atrial Fibrillation (AF) - Atrial Tachycardia (AT) - Atrial Flutter (AFL) - Atrioventricular Nodal Reentrant Tachycardia (AVNRT) - Atrioventricular Reentrant Tachycardia (AVRT) - Ventricular tachycardia, among which the most common are: - Ventricular Tachycardia (VT) - Ventricular Flutter (VFL) - Ventricular Fibrillation (VF) - Bradycardia: - Sinus Node Dysfunction - AV Node Dysfunction - Interventricular Conduction Disorder - Arrhythmogenic cardiomyopathies, among which the most common are: - Dilated Cardiomyopathy - Restrictive Cardiomyopathy - Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) Exclusion criteria (shared for all studies): - Age < 18 - Unable or unwilling to comply with study procedures - Pregnancy or of childbearing potential without adequate contraception - NYHA class IV heart failure symptoms or left ventricular ejection fraction <35%.

Study Design


Intervention

Other:
Biobank for Left atrial appendage tissue
Bodily material is used for biochemical marker assessments, histological and molecular analyses for research in cardiac arrhythmias.
Biobank for Blood
Bodily material is used for biochemical marker assessments, histological and molecular analyses for research in cardiac arrhythmias.
Biobank for One or more of following fat patches: epicardial fat, subcutaneous fat, pericardial fat, visceral fat.
Bodily material is used for biochemical marker assessments, histological and molecular analyses for research in cardiac arrhythmias.

Locations

Country Name City State
Netherlands Amsterdam University Medical Center location AMC Amsterdam

Sponsors (1)

Lead Sponsor Collaborator
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Country where clinical trial is conducted

Netherlands, 

Outcome

Type Measure Description Time frame Safety issue
Primary (new onset) atrial fibrilation obtain a comprehensive collection of patient information and material to facilitate research and gain better insight into the complex pathophysiology of the different arrhythmias 5 year follow up
Primary recurrence of cardia arrythmia obtain a comprehensive collection of patient information and material to facilitate research and gain better insight into the complex pathophysiology of the different arrhythmias 5 year follow up
See also
  Status Clinical Trial Phase
Completed NCT00376532 - Extracellular Matrix Marker of Arrhythmia Risk (EMMA) N/A
Recruiting NCT04848844 - The PAtients pResenTing With COngenital HeaRt DIseAse Register (ARTORIA-R)
Completed NCT06039397 - The Effect of Semi Fowler 30' Right Lateral on Cardiac Output in Acute Heart Failure N/A
Completed NCT04025762 - 24/7 Closed-loop in Older Subjects With Type 1 Diabetes N/A
Not yet recruiting NCT03619018 - All Inclusive KODEX - EPD™ Study Patient Specific Optimized Therapy (PSOT) Study
Completed NCT03786640 - Abbott Brady 3T MRI PMCF
Recruiting NCT05932602 - AVEIR DR Coverage With Evidence Development (CED) Study
Recruiting NCT05935007 - Aveir DR Real-World Evidence Post-Approval Study
Recruiting NCT01988064 - Face to Face vs. Group Training Methods on Pulse Rate Taking in Patients With Cardiovascular Diseases. N/A
Recruiting NCT06310707 - Arrhythmia Identification in Syncope Patients: ePatch® Versus 24h Holter N/A
Terminated NCT03481413 - Patient Specific Optimized Therapy Post-Market Clinical Follow-up Study
Recruiting NCT05443321 - Advancing Health Information Exchange (HIE) During Inter-hospital Transfer (IHT) to Improve Patient Outcomes N/A
Recruiting NCT03801681 - ARrhythmias in MYocarditis
Completed NCT03628534 - SERF VT Ablation Early Feasibility Study (EFS) N/A
Recruiting NCT05034432 - The PIVATAL Study -Study of Ventricular Arrhythmia (VTA) Ablation in Left Ventricular Assist Device (LVAD) Patients Phase 4
Recruiting NCT04856267 - Exploration of Arrhythmia Burden in Cardiac Amyloidosis Using Implantable Loop Recorders
Not yet recruiting NCT06414447 - Electrocardiogram (ECG) Validation Study
Completed NCT02401659 - Importance of Patient´s Satisfaction With Telemedicine Based on Monitoring Systems N/A
Recruiting NCT05790642 - Comparison of Different Non-invasive Methods to Assess Pulse Wave Analysis
Recruiting NCT04833712 - Stereotactic Radioablation for the Treatment of Refractory Atrial Fibrillation N/A